EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Global burden of drug-resistant tuberculosis in children: a systematic analysis for the Global Burden of Disease Study

Xuhui Liu iD, Peierdun Mijiti, Lu Xia, Sylvia M LaCourse iD, Wulan Talafuhan, Alexander W Kay iD, Yang Yang, Huarui Liu, Dan Ye, Leonardo Martinez, Shuihua Lu, Adong Shen und 4 weitere

European Respiratory Journal · 2026-10 · 68 (4) · 2501648

DOI: 10.1183/13993003.01648-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 04.06.2026. Verfasst von Xuhui Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Global Burden of Disease, Extensively Drug-Resistant Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Distinctive Program of Public Health and Preventive Medicine in Higher Education Institutions of Xinjiang Uygur Autonomous Region, National Natural Science Foundation of China, Deutsches Zentrum für Infektionsforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Paediatric tuberculosis (TB), particularly drug-resistant TB, is associated with significant mortality. However, the global burden of childhood TB remains poorly understood.

Methods

We analysed incident cases, deaths and age-standardised incidence and mortality rates among children (0–14 years) with multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and extensively drug-resistant tuberculosis (XDR-TB) using the Global Burden of Disease 2021 database. Data were stratified by age, sex, region, country and HIV/AIDS status. Annual and average annual percentage changes were assessed using joinpoint regression analysis. Secondary analyses compared adult and paediatric TB trends in the End TB era and evaluated the potential impact of the COVID-19 pandemic on childhood TB. Sensitivity analyses were performed using the latest available Global Burden of Disease 2023 database.

Results

In 2021, an estimated 32 515 (95% uncertainty interval (UI) 20 968–51 288) paediatric MDR/RR-TB incident cases and 1193 (95% UI 806–1814) XDR-TB cases occurred globally, with 5887 (95% UI 2467–11 332) and 253 (95% UI 109–508) corresponding deaths, respectively; all estimates were lower than counterfactual projections for 2021 in the absence of COVID-19. Since 2005, age-standardised incidence and mortality rates for MDR/RR-TB and mortality rates for XDR-TB have slowly trended downwards, while their proportional contributions to total incident cases and deaths have increased. Children who are female, younger, from low sociodemographic regions and HIV-co-infected are disproportionately affected. No significant impact of the End TB Strategy on paediatric TB trends was observed after 2015. Cross-dataset comparisons showed concordant principal findings.

Conclusions

The global burden of paediatric drug-resistant TB is substantial, with marked disparities across vulnerable populations and regions. Targeted interventions should be tailored to strategically address regional development status, HIV prevalence and local health policies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantGlobal Burden of DiseaseExtensively Drug-Resistant TuberculosisHumansChild, PreschoolChildFemaleInfantAdolescentIncidenceInfant, NewbornMaleCOVID-19Global HealthHIV InfectionsAntitubercular Agents

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • X. Liu, P. Mijiti and L. Xia contributed equally to this work as first authors.
  • Department of Epidemiology and Biostatistics, School of Public Health, Xinjiang Medical University, Urumqi, China.
  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Department of Medicine, Department of Global Health, Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Global TB Program, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

ORCID-Profile: Xuhui Liu, Sylvia M LaCourse, Alexander W Kay, Anna M Mandalakas, Christoph Lange, Zhen Huang

Förderung

  • Distinctive Program of Public Health and Preventive Medicine in Higher Education Institutions of Xinjiang Uygur Autonomous Region
  • National Natural Science Foundation of China
  • Deutsches Zentrum für Infektionsforschung
  • National Mega Project on Major Infectious Disease Prevention
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Liu, X., Mijiti, P., Xia, L., LaCourse, S. M., Talafuhan, W., Kay, A. W., Yang, Y., Liu, H., Ye, D., Martinez, L., Lu, S., Shen, A., Mandalakas, A. M., Li, F., Lange, C., & Huang, Z. (2026). Global burden of drug-resistant tuberculosis in children: a systematic analysis for the Global Burden of Disease Study. European Respiratory Journal, 68(4), 2501648. https://doi.org/10.1183/13993003.01648-2025

Vancouver

Liu X, Mijiti P, Xia L, LaCourse SM, Talafuhan W, Kay AW, et al. Global burden of drug-resistant tuberculosis in children: a systematic analysis for the Global Burden of Disease Study. European Respiratory Journal. 2026;68(4):2501648. doi:10.1183/13993003.01648-2025

BibTeX
@article{Liu2026,
  author = {Liu, Xuhui and Mijiti, Peierdun and Xia, Lu and LaCourse, Sylvia M and Talafuhan, Wulan and Kay, Alexander W and Yang, Yang and Liu, Huarui and Ye, Dan and Martinez, Leonardo and Lu, Shuihua and Shen, Adong and Mandalakas, Anna M and Li, Feng and Lange, Christoph and Huang, Zhen},
  title = {Global burden of drug-resistant tuberculosis in children: a systematic analysis for the Global Burden of Disease Study},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {4},
  pages = {2501648},
  doi = {10.1183/13993003.01648-2025}
}
Kostenlos starten →